arguments de vente des compagnies pharmaceutiques ou de leur représentant lors de visite en officine.

Academic detailing is the term for providing science-based, impartial information about prescription drugs, from a nonindustry source, to physicians and other prescribers.

By contrast, “pharmaceutical detailing” describes sales visits in which drug company representatives tout the benefits of their companies’ products. Critics of pharmaceutical detailing say that new, expensive drugs often are introduced in these visits to replace older medications that have a lower price tag and may be just as effective as their replacements.
www.maine.gov/legis/housedems/news/ld_839_treat.htm

--------------------------------------------------
Note added at 1 hr (2010-11-12 10:36:12 GMT)
--------------------------------------------------

Academic detailing is “university or non-commercial-based educational outreach.”[1] The process involves face-to-face education of prescribers by trained health care professionals, typically pharmacists, physicians, or nurses. The goal of academic detailing is to change prescribing of targeted drugs to be consistent with medical evidence, support patient safety, and to be cost-effective medication choices. A key component of non-commercial or university-based academic detailing programs is that they (academic detailers, management, staff, program developers, etc.) do not have any financial links to the pharmaceutical industry. Academic detailing has been studied for over 25 years[2] and is effective at improving prescribing of targeted medications about 5% from baseline.[3]
http://en.wikipedia.org/wiki/Academic_detailing

--------------------------------------------------
Note added at 1 hr (2010-11-12 10:38:48 GMT)
--------------------------------------------------

Donc tous les pays n'autorisent pas à vendre les médicaments en utilisant comme argumentaire les publications scientifiques.